GW PHARMACEUTICALS

WIPO WIPO 2019

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark GW PHARMACEUTICALS was filed as Word mark on 02/28/2019 at the World Intellectual Property Organization.

Trademark Details Last update: July 3, 2023

Trademark form Word mark
File reference 1459268
Register number UK00003355223
Countries Australia Colombia European Community Israel India Japan South Korea Mexico New Zealand Turkey
Base trademark GB No. UK00003355223, February 8, 2019
Application date February 28, 2019
Expiration date February 28, 2029

Trademark owner

Sovereign House
Histon, Cambridge CB24 9BZ
GB

Trademark representatives

Winthrop & Weinstine, 225 South Sixth Street, US

goods and services

05 Pharmaceutical, medical and veterinary preparations and substances; pharmaceutical preparations and substances for the treatment of epilepsy; pharmaceutical preparations and substances for the treatment of pediatric epilepsy; pharmaceutical preparations and substances for the treatment of convulsions, seizures, Dravet syndrome, Lennox-Gastaut syndrome, intractable childhood epilepsy with generalized tonic-clonic seizures, generalized epilepsy with febrile seizures plus, Doose syndrome and chromosome disorders; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions; medicinal infusions for the treatment of epilepsy, convulsions and seizures; pure extracts of medicinal plants and herbs; foodstuffs for medicinal purposes; dietary supplements for humans and animals; dietetic food and substances adapted for medical or veterinary use; food for babies; herb teas for medicinal purposes; medications for the treatment of multiple sclerosis, pain associated with cancer, neuropathies and rheumatoid arthritis; medicines for the treatment of symptoms including pain, muscle spasticity and spasms, bladder problems and sleep disorders; medications for the treatment of conditions to which neuropathic pain is associated, including multiple sclerosis, cancer, spinal cord injury, physical trauma and peripheral neuropathy resulting from diabetes; medicines for the treatment of anorexia-cachexia, the result of cancer or AIDS, and nausea, and secondary vomiting due to chemotherapy treatments
31 Agricultural and horticultural products; seeds; seedlings for plant breeding; flowers; plants; plant residues (raw materials); fresh herbs; foodstuffs and beverages for animals

Trademark history

Date Document number Area Entry
June 22, 2023 2023/26 Gaz Correction
June 16, 2023 2023/25 Gaz Correction
March 17, 2023 2023/23 Gaz Correction
April 8, 2021 2021/16 Gaz MX RAW: Rule 18ter(2)(i) GP following a provisional refusal
November 26, 2020 2020/49 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
July 16, 2020 2020/29 Gaz KR Rejection
June 4, 2020 2020/23 Gaz JP Rejection
June 1, 2020 2020/28 Gaz IL RAW: Rule 18ter(2)(ii) GP following a provisional refusal
March 4, 2020 2020/10 Gaz MX Rejection
February 25, 2020 2020/13 Gaz IN RAW: Rule 18ter(2)(ii) GP following a provisional refusal
December 31, 2019 2020/1 Gaz TR Rejection
December 10, 2019 2019/50 Gaz KR Rejection
November 27, 2019 2019/48 Gaz CO Rejection
October 29, 2019 2019/45 Gaz IL Rejection
October 17, 2019 2019/42 Gaz AU Rejection
September 10, 2019 2019/37 Gaz EM Rejection
September 3, 2019 2019/36 Gaz NZ Rejection
May 27, 2019 2019/23 Gaz IN Rejection
February 28, 2019 2019/12 Gaz GB Registration

ID: 141459268